Market Whales and Their Recent Bets on LLY Options
Market Whales and Their Recent Bets on LLY Options
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 563.62, with a total volume reaching 297.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $430.0 to $980.0, throughout the last 30 days.Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co (NYSE:LLY) revealed 15 unusual trades.
金融巨頭顯然看跌禮來。我們分析了禮來（紐交所代碼：LLY）期權歷史記錄，發現有15次飛凡交易。
Delving into the details, we found 26% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $881,458, and 10 were calls, valued at $903,584.
深入分析後，我們發現有26%的交易員看漲，而33%的交易員表現出看淡的趨勢。在我們發現的所有交易中，有5次看跌，價值爲881,458美元，10次看漲，價值爲903,584美元。
Predicted Price Range
預測價格區間
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $430.0 and $980.0 for Eli Lilly and Co, spanning the last three months.
在評估成交量和未平倉利潤後，可以明顯看出市場主要運營商正集中在430.0美元到980.0美元的價格區間內，爲期三個月的禮來行業板塊。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 563.62, with a total volume reaching 297.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $430.0 to $980.0, throughout the last 30 days.
在今天的交易環境中，禮來期權的平均未平倉利潤爲563.62，總成交量達到297.00。下圖描述了在430.0美元到980.0美元罷工價格走廊內，類型爲高價值的交易中，禮來的看漲看跌期權成交量和未平倉利潤的進展情況，時間跨度爲最近30天。
Eli Lilly and Co Option Volume And Open Interest Over Last 30 Days
Eli Lilly and Co過去30天期權成交量和持倉量
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | SWEEP | BEARISH | 07/26/24 | $64.0 | $61.35 | $64.0 | $935.00 | $640.0K | 150 | 100 |
| LLY | CALL | SWEEP | BULLISH | 01/17/25 | $142.9 | $137.8 | $140.78 | $780.00 | $281.9K | 3.5K | 0 |
| LLY | CALL | SWEEP | NEUTRAL | 01/17/25 | $142.7 | $138.6 | $140.68 | $780.00 | $253.4K | 3.5K | 41 |
| LLY | PUT | TRADE | BULLISH | 07/26/24 | $77.3 | $72.3 | $72.3 | $940.00 | $108.4K | 103 | 15 |
| LLY | PUT | TRADE | BEARISH | 07/26/24 | $14.6 | $10.85 | $14.6 | $870.00 | $73.0K | 431 | 0 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看跌 | SWEEP | 看淡 | 07/26/24 | $64.0 | $61.35 | $64.0 | $935.00 | $640.0K | 150 | 100 |
| LLY | 看漲 | SWEEP | 看好 | 01/17/25 | $142.9 | $137.8 | $140.78 | $780.00 | $281.9K | 3.5K | 0 |
| LLY | 看漲 | SWEEP | 中立 | 01/17/25 | $142.7 | $138.6美元 | $140.68 | $780.00 | $253.4K | 3.5K | 41 |
| LLY | 看跌 | 交易 | 看好 | 07/26/24 | $77.3 | $72.3 | $72.3 | $940.00 | $108.4K | 103 | 15 |
| LLY | 看跌 | 交易 | 看淡 | 07/26/24 | 14.6美元 | $10.85 | 14.6美元 | $870.00 | $73.0K | 431 | 0 |
About Eli Lilly and Co
關於禮來
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的維津尼奧；馬天尼羅、澤普邦、賈達信、特魯利康、胰島素諾和人用胰島素用於糖尿病；以及用於免疫學的塔吉特和優泰樂。
After a thorough review of the options trading surrounding Eli Lilly and Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
經過對禮來期權交易的全面審查後，我們將進一步審查該公司。這包括對其當前市場地位和表現的評估。
Current Position of Eli Lilly and Co
禮來當前持倉
- With a volume of 73,482, the price of LLY is up 0.45% at $869.85.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 16 days.
- LLY的成交量爲73,482美元，價格上漲0.45%，至869.85美元。
- RSI指標暗示該標的股票目前處於超買和超賣的中立區間。
- 下一個收益預計將在16天內發佈。
Professional Analyst Ratings for Eli Lilly and Co
禮來的專業分析師評級
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $959.0.
在過去的一個月中，有5位行業分析師分享了他們對該股票的見解，提出了959.0美元的平均目標價。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Consistent in their evaluation, an analyst from Berenberg keeps a Buy rating on Eli Lilly and Co with a target price of $1000.
- An analyst from Barclays persists with their Overweight rating on Eli Lilly and Co, maintaining a target price of $1025.
- Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $1000.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- 考慮到擔憂，來自康泰菲茲傑拉德的分析師將其評級下調爲超配，並制定了一個新的股票價格目標爲885美元。
- Berenberg的一位分析師在評估中堅持對禮來股的買入評級，目標價爲1000美元。
- 巴克萊銀行的一位分析師堅持對禮來股票的超配評級，維持其1025美元的目標價。
- 考慮到擔憂，Truist Securities的分析師將評級下調爲買入，將目標價設定爲1000美元。
- 爲了謹慎起見，Cantor Fitzgerald的分析師將其評級下調爲超重，設定了885美元的價格目標。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。